191 related articles for article (PubMed ID: 38532450)
21. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Whittemore VH; Chen D; Sahmoud T; Shah G; Lincy J; Lebwohl D; Budde K
Lancet; 2013 Mar; 381(9869):817-24. PubMed ID: 23312829
[TBL] [Abstract][Full Text] [Related]
22. Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec: Prevalence and Health-care Utilization.
Kristof AS; Zhi Li P; Major P; Landry JS
Chest; 2015 Aug; 148(2):444-449. PubMed ID: 25789699
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary lymphangioleiomyomatosis and renal angiomyolipoma in a patient with systemic lupus erythematosus: A case report.
Koh JS; Oh S; Chung C
Medicine (Baltimore); 2022 Sep; 101(38):e30554. PubMed ID: 36197220
[TBL] [Abstract][Full Text] [Related]
24. Computed tomographic features of lymphangioleiomyomatosis: evaluation in 138 patients.
Tobino K; Johkoh T; Fujimoto K; Sakai F; Arakawa H; Kurihara M; Kumasaka T; Koike K; Takahashi K; Seyama K
Eur J Radiol; 2015 Mar; 84(3):534-541. PubMed ID: 25544557
[TBL] [Abstract][Full Text] [Related]
25. Lymphangioleiomyomatosis.
Xu KF; Xu W; Liu S; Yu J; Tian X; Yang Y; Wang ST; Zhang W; Feng R; Zhang T
Semin Respir Crit Care Med; 2020 Apr; 41(2):256-268. PubMed ID: 32279296
[TBL] [Abstract][Full Text] [Related]
26. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
[TBL] [Abstract][Full Text] [Related]
27. Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.
Cai Y; Guo H; Wang W; Li H; Sun H; Shi B; Zhang Y
Orphanet J Rare Dis; 2018 Mar; 13(1):43. PubMed ID: 29587809
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and outcomes of male patients with lymphangioleiomyomatosis: A review.
Zhang H; Hu Z; Wang S; Wu K; Yang Q; Song X
Medicine (Baltimore); 2022 Dec; 101(52):e32492. PubMed ID: 36596036
[TBL] [Abstract][Full Text] [Related]
29. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
[No Abstract] [Full Text] [Related]
30. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.
Kingswood JC; Jozwiak S; Belousova ED; Frost MD; Kuperman RA; Bebin EM; Korf BR; Flamini JR; Kohrman MH; Sparagana SP; Wu JY; Brechenmacher T; Stein K; Berkowitz N; Bissler JJ; Franz DN
Nephrol Dial Transplant; 2014 Jun; 29(6):1203-10. PubMed ID: 24729041
[TBL] [Abstract][Full Text] [Related]
31. Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis.
Chernbumroong S; Johnson J; Gupta N; Miller S; McCormack FX; Garibaldi JM; Johnson SR
Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33303533
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of sirolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: a systematic review.
Peng ZF; Yang L; Wang TT; Han P; Liu ZH; Wei Q
J Urol; 2014 Nov; 192(5):1424-30. PubMed ID: 24813310
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM).
Shen L; Xu W; Gao J; Wang J; Huang J; Wang Y; He Y; Yang Y; Tian X; Xu KF
Orphanet J Rare Dis; 2021 Mar; 16(1):133. PubMed ID: 33731151
[TBL] [Abstract][Full Text] [Related]
34. Tuberous sclerosis complex presenting as pulmonary lymphangioleiomyomatosis--a clinicoradiological diagnosis.
Gupta K; Goyal A; Saggar K; Banerjee A
Pan Afr Med J; 2015; 20():207. PubMed ID: 26113938
[TBL] [Abstract][Full Text] [Related]
35. Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy.
Yu J; Parkhitko AA; Henske EP
Proc Am Thorac Soc; 2010 Feb; 7(1):48-53. PubMed ID: 20160148
[TBL] [Abstract][Full Text] [Related]
36. Lymphangioleiomyomatosis: a review of the literature.
Hancock E; Osborne J
Respir Med; 2002 Jan; 96(1):1-6. PubMed ID: 11863203
[TBL] [Abstract][Full Text] [Related]
37. A rare pulmonary lymphangioleiomyomatosis disease in a male with tuberous sclerosis complex.
Kabi A; Panda S; Sama S; Kumar S; Kaeley N; Sogal P S
Respir Med Case Rep; 2020; 31():101150. PubMed ID: 32695569
[TBL] [Abstract][Full Text] [Related]
38. CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex.
Wang W; Guo H; Shi B; Sun H; Li H; Zhang Y; Cai Y
Int Urol Nephrol; 2019 Apr; 51(4):671-676. PubMed ID: 30756282
[TBL] [Abstract][Full Text] [Related]
39. Lymphangioleiomyomatosis (LAM) presenting as recurrent pneumothorax in an infant with tuberous sclerosis: treated successfully with sirolimus.
Takia L; Jat KR; Mandal A; Kabra SK
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413450
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis.
Budde K; Zonnenberg BA; Frost M; Cheung W; Urva S; Brechenmacher T; Stein K; Chen D; Kingswood JC; Bissler JJ
Br J Clin Pharmacol; 2016 May; 81(5):958-70. PubMed ID: 26580489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
